/PRNewswire/ – AMRI announced today that Dawn M. Von Rohr, will join AMRI as Sr. Vice President, API, effective January 25, 2016. Ms. Von Rohr will report to George Svokos, Chief Operating Officer, and will be a member of the executive team led by President and Chief Executive Officer, William Marth. Ms. Von Rohr will have responsibility for setting and implementing the strategic direction for AMRI’s growing Active Pharmaceutical Ingredient (API) business unit and for achieving the financial results of that business, AMRI’s largest business unit.
“We are pleased to welcome Dawn to AMRI,” said Mr. Svokos. “We are confident that she brings the expertise and dynamic leadership to define and drive the next phase of growth for the API business and that her abilities in successfully leading a global, commercial API business will enhance our customers’ experience as we continue to provide them with the complex API products and services they need.”
Ms. Von Rohr comes to AMRI from Mallinckrodt Pharmaceuticals, where she was Vice President and General Manager, Global APIs. In this role, she was part of the executive leadership team that set the direction and executed the successful spin-out of Mallinckrodt from Covidien, and she successfully led a business that met and exceeded profit targets each year. Ms. Von Rohr brings her strategic pricing, product rationalization and business building experience.
Ms. Von Rohr began her career within the Quality and Research & Development Department at Schering Plough and then began a 22-year career with Mallinckrodt Pharmaceuticals. With a technical and business education, she transitioned to Sales and Marketing holding increasing responsibilities including Business Manager, Director Technology and Business Development; Senior Global Business Director; and Vice President and General Manager. Dawn was an extended Board Member of the Drug, Chemical, and Associated Technologies (DCAT) Organization from 2013 to 2015.
Ms. Von Rohr has a Bachelor of Arts degree in Chemistry from Vanderbilt University, and a Master of Business Administration degree with a concentration in Marketing from Washington University in St. Louis.
Industrial technology provider Husky Injection Molding Systems is partnering with injection molding specialist Chem-Trend to design a color change system for packaging manufacturers to ensure repeatability and a more optimized and accurate process.
The agreement encompasses 120 filling stations, as well as OMV’s wholesale business in Slovenia. The transaction is subject to required regulatory approvals and closing is expected in 2022.
Xavier Aeby and Gustav Nyström from Empa’s Cellulose & Wood Materials lab invented a fully printed biodegradable battery made from cellulose and other non-toxic components.